Skip to content
No picture yet

Apo-Cabergoline 0.5 mg – DIN 02455897

Apo-Cabergoline is Cabergoline 0.5 mg (tablet), sold in Canada. It is used for Parkinson's disease, adenoma and hyperprolactinemia. It is supplied by Apotex Inc. We don't have a photo or description of what this pill looks like yet, so check the name and code on the box or bottle, and ask a pharmacist before taking it. Its official Health Canada listing links to the product monograph, which describes the tablets.

Sold in Canada

Cabergoline 0.5 mg

Brand
Apo-Cabergoline
Strength
0.5 mg
Used for
Parkinson's disease, adenoma and hyperprolactinemia
Form
Tablet
Manufacturer
Apotex Inc
Drug class
Ergot derivative
Sold in
Canada
DIN
02455897

Source: Health Canada's Drug Product Database. Last checked .

Report a mistake

Please do not include personal health information. For questions about your medicine, ask a pharmacist.

All Cabergoline pills and guides

What is Cabergoline used for?

Cabergoline is used for Parkinson's disease, adenoma and hyperprolactinemia.

Medicine type
Ergot derivative
Official uses from the US prescribing label

Cabergoline tablets is an ergot derivative indicated for the treatment of hyperprolactinemic disorders, either idiopathic or due to pituitary adenomas in adults.

Limitations of Use

Avoid use of cabergoline tablets for the inhibition or suppression of postpartum physiologic lactation because of the risk of serious adverse reactions.

From the FDA-approved label on DailyMed (published Aug 03, 2026).

Doctors sometimes prescribe a medicine for other reasons too. If you are not sure what yours is for, ask your pharmacist.

Is this your medicine? Check the box

  • The box or bottle shows DIN 02455897.
  • It names Apo-Cabergoline, Cabergoline 0.5 mg.
  • A loose pill is a different matter: without a description of its markings, a pharmacist has to confirm what it is.

Sold in Canada as Apo-Cabergoline by Apotex Inc.

In Canada: prescription only.

Ingredients

Active: Cabergoline

Other Cabergoline pills